Inactive Instrument

Calendar Pfizer Inc Nyse

Equities

End-of-day quote Nyse
- USD - Intraday chart for Pfizer Inc

Chart calendar Pfizer Inc

0a110b77e2952ee125a7.05MFOVtxAdmpXG4dkeIgsJ_RNM-7_F9-d9tJCAKao84.q6VdXz08V6jsZQFY_JtiiM-gQrjJzQ1NWo16QWP1xZql8U5yAVxgsc0RNw~46f1196d9d03371f80a4f8956d81ae25

Upcoming events on Pfizer Inc

2024-05-08 Ex-dividend day
2024-05-31 15:45 American Society of Clinical Oncology Annual Meeting - Abstract No: LBA8503
2024-06-01 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 3108
2024-06-01 16:00 American Society of Clinical Oncology Annual Meeting - Abstract No: LBA7005
2024-06-01 16:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5005
2024-06-01 16:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 3006
2024-06-01 17:30 American Society of Clinical Oncology Annual Meeting - Abstract No: 8521
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4563
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4562
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5063
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5061
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 5021
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 1105
2024-06-02 10:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 1111
2024-06-03 09:00 American Society of Clinical Oncology Annual Meeting - Abstract No: 4503

Past events on Pfizer Inc

2024-05-01 10:00 Q1 2024 Earnings Call
2024-05-01 06:45 Q1 2024 Earnings Release
2024-04-25 09:00 Annual General Meeting
2024-03-12 08:00 Leerink Partners Global Biopharma Conference
2024-03-04 11:10 TD Cowen Health Care Conference
2024-02-29 13:00 Investor Day - Oncology Innovation
2024-01-30 10:00 Q4 2023 Earnings Call
2024-01-30 06:45 Q4 2023 Earnings Release
2024-01-24 Ex-dividend day
2024-01-08 18:00 JPMorgan Healthcare Conference
2023-12-13 08:30 Q4 2024 Guidance Call
2023-12-11 20:15 American Society of Hematology Meeting - Abstract Number -1054
2023-12-11 19:30 American Society of Hematology Meeting - Abstract Number -1057
2023-12-09 19:45 American Society of Hematology Meeting - Abstract Number -274
2023-12-09 19:30 American Society of Hematology Meeting - Abstract Number -285
2023-12-09 12:45 American Society of Hematology Meeting - Abstract Number -14
2023-11-28 10:50 Evercore ISI HealthCONx Conference
2023-11-09 12:35 Truist Securities Healthcare Conference
2023-11-08 Ex-dividend day
2023-10-31 10:00 Q3 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
51 750
51 807
-0.11%
41 908
48 014
-12.72%
81 288
81 781
-0.6%
100 330
100 373
-0.04%
58 496
59 105
-1.03%

60 268

EBITDA
Million USD
Released
Forecast
Spread
21 097
22 824
-7.57%
17 801
21 398
-16.81%
25 426
29 444
-13.65%
42 336
44 597
-5.07%
15 590
11 249
38.59%

20 313

EBIT
Million USD
Released
Forecast
Spread
19 420
19 883
-2.33%
13 024
17 362
-24.99%
20 235
26 662
-24.11%
37 272
40 403
-7.75%
9 300
8 509
9.3%

17 032

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
17 682
22 426
-21.15%
7 497
13 166
-43.06%
24 311
19 569
24.23%
34 729
39 058
-11.08%
1 058
2 301
-54.02%

9 561

Net income
Million USD
Released
Forecast
Spread
16 273
19 053
-14.59%
9 616
16 066
-40.15%
21 979
22 567
-2.6%
31 372
33 053
-5.09%
2 119
3 040
-30.29%

7 184

EPS
USD
Released
Forecast
Spread
2,87
3,40
-15.62%
1,71
3,07
-44.24%
3,85
3,89
-0.9%
5,47
5,85
-6.45%
0,37
0,72
-48.44%

1,41

Announcement Date28/01/2002/02/2108/02/2231/01/2330/01/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
23 838
24 203
-1.51%
25 661
24 734
3.75%
27 742
26 199
5.89%
22 638
21 091
7.33%
24 290
24 393
-0.42%
18 282
16 488
10.88%
12 734
13 398
-4.96%
13 232
13 429
-1.47%
14 249
14 396
-1.02%
14 879
13 923
6.87%

13 041


14 805


17 722


15 680

EBITDA
Million USD
Released
Forecast
Spread
4 403
6 196
-28.93%
11 135
13 710
-18.78%
13 583
12 434
9.25%
10 325
10 332
-0.06%
6 772
7 436
-8.92%
7 857
7 513
4.58%
4 925
4 000
23.13%
-1 244
-1 511
17.64%
1 340
-1 298
203.24%

4 403


3 759


4 681


4 537




EBIT
Million USD
Released
Forecast
Spread
3 126
5 610
-44.28%
9 948
9 738
2.16%
12 408
11 055
12.24%
9 142
9 092
0.55%
5 253
6 886
-23.71%
6 370
6 471
-1.56%
3 319
3 634
-8.68%
-1 625
-1 827
11.07%
-330
-1 404
76.5%
5 912
3 667
61.24%

3 423


3 804


3 977




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



9 050








5 231
7 425
-29.55%






-3 352
2 207
-251.88%
-4 129
-3 139
-31.54%
3 421
2 992
14.34%

2 061


2 651


3 182




Net income
Million USD
Released
Forecast
Spread
3 393
5 046
-32.75%
7 864
8 418
-6.58%
9 906
9 799
1.09%
8 608
7 631
12.8%
4 995
5 667
-11.86%
5 543
4 495
23.31%
2 327


-2 382
-3 241
26.49%
-3 369
-2 371
-42.12%
3 115
1 951
59.69%

1 188


1 362


2 208




EPS
USD
Released
Forecast
Spread
0,59
0,74
-20.27%
1,37
1,60
-14.17%
1,73
1,64
5.73%
1,51
1,37
10.21%
0,87
0,69
25.48%
0,97
0,85
14.79%
0,41


-0,42
-0,51
16.83%
-0,60
-0,43
-41.06%
0,55
0,34
61.01%

0,20


0,28


0,41




Announcement Date08/02/2203/05/2228/07/2201/11/2231/01/2302/05/2301/08/2331/10/2330/01/2401/05/24----